Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568360 · ClinicalTrials.gov registry record
Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00568360: Clinical Trial study, sponsored by Stanford University.
NCT00568360 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00568360 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Endoscopy is a standard part of the evaluation of patients with head and neck cancer used for determining the extent of tumor involvement. However, not all areas involved by tumor are apparent visually. Preliminary results indicate that compared with normal tissues, tumors have abnormal levels of capillary oxygenation. The purpose of this study is to determine the ability of non-pulsatile visible light tissue oxygen monitoring to differentiate normal and tumor tissue based on capillary oxygenation during endoscopy Should this be possible, this method could be used to mark tumor extent and invasion, even when that invasion is up to 5mm blow the tissue surface.
Interventions
- DEVICE Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2004-02 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568360
The ClinicalTrials.gov registry entry for NCT00568360 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oximeter is the first listed.
NCT00568360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00568360 about?
NCT00568360 is a clinical study titled "Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer". Endoscopy is a standard part of the evaluation of patients with head and neck cancer used for determining the extent of tumor involvement. However, not all areas involved by tumor are apparent visually. Preliminary results indicate that compared with normal tissues, tumors have abnormal levels of ca...
What is the current status of trial NCT00568360?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2004-02. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00568360?
The interventions under investigation include: Oximeter (DEVICE).
Who is sponsoring clinical trial NCT00568360?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.